206 related articles for article (PubMed ID: 36044030)
41. First-in-Human Study of
Drake LR; Wu Y; Naganawa M; Asch R; Zheng C; Najafzadeh S; Pracitto R; Lindemann M; Li S; Ropchan J; Labaree D; Emery PR; Dias M; Henry S; Nabulsi N; Matuskey D; Hillmer AT; Gallezot JD; Carson RE; Cai Z; Huang Y
J Nucl Med; 2024 Feb; 65(3):462-9. PubMed ID: 38360052
[TBL] [Abstract][Full Text] [Related]
42. An optimized radiosynthesis of [
Holt DP; Kumar D; Nimmagadda S; Dannals RF
J Labelled Comp Radiopharm; 2023 Feb; 66(2):47-54. PubMed ID: 36627757
[TBL] [Abstract][Full Text] [Related]
43. An improved radiosynthesis of [
Holt DP; Dannals RF
J Labelled Comp Radiopharm; 2022 Oct; 65(12):302-308. PubMed ID: 36000273
[TBL] [Abstract][Full Text] [Related]
44. Translation of HDAC6 PET Imaging Using [
Celen S; Rokka J; Gilbert TM; Koole M; Vermeulen I; Serdons K; Schroeder FA; Wagner FF; Bleeser T; Hightower BG; Hu J; Rahal D; Beyzavi H; Vanduffel W; Van Laere K; Kranz JE; Hooker JM; Bormans G; Cawthorne CJ
ACS Chem Neurosci; 2020 Apr; 11(7):1093-1101. PubMed ID: 32159328
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of [
Roselt P; Cullinane C; Noonan W; Elsaidi H; Eu P; Wiebe LI
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287202
[TBL] [Abstract][Full Text] [Related]
46. Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer.
Guan B; Zhou N; Wu CY; Li S; Chen YA; Debnath S; Hofstad M; Ma S; Raj GV; He D; Hsieh JT; Huang Y; Hao G; Sun X
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884893
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
[TBL] [Abstract][Full Text] [Related]
48. Proof-of-concept optimization of a copper-mediated
Lu Y; He Y; Schibli R; Mu L; van Dam RM
Lab Chip; 2023 Oct; 23(21):4652-4663. PubMed ID: 37818614
[TBL] [Abstract][Full Text] [Related]
49. A facile synthesis of precursor for the σ-1 receptor PET radioligand [
Marešová A; Jurášek M; Drašar PB; Dolenský B; Prokudina EA; Shalgunov V; Herth MM; Cumming P; Popkov A
J Labelled Comp Radiopharm; 2024 Feb; 67(2):59-66. PubMed ID: 38171540
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic Characterization of [
Becker G; Warnier C; Serrano ME; Bahri MA; Mercier J; Lemaire C; Salmon E; Luxen A; Plenevaux A
Mol Pharm; 2017 Aug; 14(8):2719-2725. PubMed ID: 28651055
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
52. Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography.
Ritawidya R; Wenzel B; Teodoro R; Toussaint M; Kranz M; Deuther-Conrad W; Dukic-Stefanovic S; Ludwig FA; Scheunemann M; Brust P
Molecules; 2019 Nov; 24(22):. PubMed ID: 31731831
[TBL] [Abstract][Full Text] [Related]
53. Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use.
Stephenson NA; Holland JP; Kassenbrock A; Yokell DL; Livni E; Liang SH; Vasdev N
J Nucl Med; 2015 Mar; 56(3):489-92. PubMed ID: 25655630
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
[TBL] [Abstract][Full Text] [Related]
55. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
[TBL] [Abstract][Full Text] [Related]
56. Copper-mediated nucleophilic radiofluorination of [
Yu HM; Li CY; Liu SW; Yang CH; Chang Y
J Labelled Comp Radiopharm; 2021 May; 64(6):228-236. PubMed ID: 33570188
[TBL] [Abstract][Full Text] [Related]
57. Next Generation Copper Mediators for the Efficient Production of
Hoffmann C; Kolks N; Smets D; Haseloer A; Gröner B; Urusova EA; Endepols H; Neumaier F; Ruschewitz U; Klein A; Neumaier B; Zlatopolskiy BD
Chemistry; 2023 Jan; 29(2):e202202965. PubMed ID: 36214204
[TBL] [Abstract][Full Text] [Related]
58. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
59. Automation of the radiosynthesis and purification procedures for [18F]Fluspidine preparation, a new radiotracer for clinical investigations in PET imaging of σ(1) receptors in brain.
Maisonial-Besset A; Funke U; Wenzel B; Fischer S; Holl K; Wünsch B; Steinbach J; Brust P
Appl Radiat Isot; 2014 Feb; 84():1-7. PubMed ID: 24291352
[TBL] [Abstract][Full Text] [Related]
60. Validation of a good manufacturing practice procedure for the production of [
Cortés González MA; Högnäsbacka AA; Halldin C; Schou M
J Labelled Comp Radiopharm; 2024 May; 67(6):245-249. PubMed ID: 38124264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
